Literature DB >> 32277047

Excess of de novo variants in genes involved in chromatin remodelling in patients with marfanoid habitus and intellectual disability.

Martin Chevarin1, Yannis Duffourd1,2, Rebecca A Barnard3, Jean-Baptiste Rivière1,2, Brian J O'Roak3, Laurence Faivre4,2,5,6, Sébastien Moutton1,5,7, François Lecoquierre1, Fatma Daoud1, Paul Kuentz1,2, Caroline Cabret1, Julien Thevenon1,5, Elodie Gautier2, Patrick Callier1,2, Judith St-Onge1, Thibaud Jouan1, Didier Lacombe7, Marie Ange Delrue7, Cyril Goizet7, Fanny Morice-Picard7, Julien Van-Gils7, Arnold Munnich8, Stanislas Lyonnet8, Valérie Cormier-Daire8, Geneviève Baujat8, Muriel Holder9, Florence Petit9, Bruno Leheup10, Sylvie Odent11, Pierre-Simon Jouk12, Gipsy Lopez12, David Geneviève13, Patrick Collignon14, Dominique Martin-Coignard15, Aurélia Jacquette16, Laurence Perrin17, Audrey Putoux18, Elisabeth Sarrazin19, Khadija Amarof19, Isabelle Missotte20, Christine Coubes13, Sujatha Jagadeesh21, Elisabetta Lapi22, Florence Demurger23, Alice Goldenberg24, Martine Doco-Fenzy25, Cyril Mignot16, Delphine Héron16, Nolwenn Jean-Marçais2, Alice Masurel5, Salima El Chehadeh5, Nathalie Marle1,2, Frédéric Huet2,26, Christine Binquet27, Gwenaëlle Collod-Beroud28, Pauline Arnaud29, Nadine Hanna29, Catherine Boileau29, Guillaume Jondeau29, Robert Olaso30, Doris Lechner30, Charlotte Poe1, Mirna Assoum1, Virginie Carmignac1, Laurence Duplomb1, Frédéric Tran Mau-Them1, Christophe Philippe1, Antonio Vitobello1, Ange-Line Bruel1, Anne Boland30, Jean-François Deleuze30, Christel Thauvin-Robinet1,2,6.   

Abstract

PURPOSE: Marfanoid habitus (MH) combined with intellectual disability (ID) (MHID) is a clinically and genetically heterogeneous presentation. The combination of array CGH and targeted sequencing of genes responsible for Marfan or Lujan-Fryns syndrome explain no more than 20% of subjects.
METHODS: To further decipher the genetic basis of MHID, we performed exome sequencing on a combination of trio-based (33 subjects) or single probands (31 subjects), of which 61 were sporadic.
RESULTS: We identified eight genes with de novo variants (DNVs) in at least two unrelated individuals (ARID1B, ATP1A1, DLG4, EHMT1, NFIX, NSD1, NUP205 and ZEB2). Using simulation models, we showed that five genes (DLG4, NFIX, EHMT1, ZEB2 and ATP1A1) met conservative Bonferroni genomewide significance for an excess of the observed de novo point variants. Overall, at least one pathogenic or likely pathogenic variant was identified in 54.7% of subjects (35/64). These variants fell within 27 genes previously associated with Mendelian disorders, including NSD1 and NFIX, which are known to be mutated in overgrowth syndromes.
CONCLUSION: We demonstrated that DNVs were enriched in chromatin remodelling (p=2×10-4) and genes regulated by the fragile X mental retardation protein (p=3×10-8), highlighting overlapping genetic mechanisms between MHID and related neurodevelopmental disorders. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  chromatin remodeling; de novo variants; exome sequencing; intellectual deficiency; marfanoid habitus

Mesh:

Substances:

Year:  2020        PMID: 32277047     DOI: 10.1136/jmedgenet-2019-106425

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  3 in total

1.  Allan-Herndon-Dudley syndrome in a female patient and related mechanisms.

Authors:  Caroline Olivati; Bianca Pereira Favilla; Erika Lopes Freitas; Bibiana Santos; Maria Isabel Melaragno; Vera Ayres Meloni; Flavia Piazzon
Journal:  Mol Genet Metab Rep       Date:  2022-05-07

Review 2.  Chromatin Remodeling in the Brain-a NuRDevelopmental Odyssey.

Authors:  Sarah Larrigan; Sujay Shah; Alex Fernandes; Pierre Mattar
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

3.  Comprehensive Genetic Testing for Pediatric Hypertrophic Cardiomyopathy Reveals Clinical Management Opportunities and Syndromic Conditions.

Authors:  Dana B Gal; Ana Morales; Susan Rojahn; Tom Callis; John Garcia; James R Priest; Rebecca Truty; Matteo Vatta; Robert L Nussbaum; Edward D Esplin; Seth A Hollander
Journal:  Pediatr Cardiol       Date:  2021-10-29       Impact factor: 1.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.